Agur, Timna
Steinmetz, Tali
Goldman, Shira
Zingerman, Boris
Bielopolski, Dana
Nesher, Eviatar
Fattal, Ittai
Meisel, Eshcar
Rozen-Zvi, Benaya
Article History
Received: 21 December 2024
Accepted: 11 February 2025
First Online: 28 February 2025
Declarations
:
: This study protocol was reviewed and approved by the local Ethics Committee of the Rabin Medical Center, Israel, approval number RMC.
: Due to the retrospective nature of the research, patient consent was not required according to the Rabin Medical Center ethics committee.
: BRZ reports a consulting fee from Fresenius Medicare and lecturer fee from AstraZeneca plc. BZ reports consulting fee from Fresenius Medicare. All other authors have no conflicts of interest to disclose as described by the ‘Kidney and Blood pressure research’ Journal.